Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

10,761 total articles

Goldgroup Mining: A Small-Cap Gold Bet with Quiet Asymmetric Upside

Goldgroup Mining: A Small-Cap Gold Bet with Quiet Asymmetric Upside

Goldgroup Mining is a micro-cap gold explorer/producer that flies under the radar. For traders willing to accept thin liquidity and event risk, the name offers asymmetric upside: modest near-term operational catalysts could re-rate the stock while a deeper gold-price recovery would amplify returns. This is a high-risk, high-reward trade plan with e…

Molson Coors Looks Too Cheap — A Tactical Long with a Defined Exit

Molson Coors Looks Too Cheap — A Tactical Long with a Defined Exit

Molson Coors (TAP) is trading like a distressed name while still generating healthy free cash flow and paying a 4.4% yield. At roughly $40.75, the shares bake in continued operational deterioration. I think that is an overly pessimistic price. This trade outlines a mid-to-long horizon long with precise entry, stop and target levels and a clear set …

Prosperity Bancshares: Cheap Relative to Franchise Strength — Buy on NIM Tailwinds and Stellar Deal Flow

Prosperity Bancshares: Cheap Relative to Franchise Strength — Buy on NIM Tailwinds and Stellar Deal Flow

Prosperity Bancshares (PB) trades below book and above a reasonable earnings multiple while it ramps scale from the Stellar deal and benefits from improving net interest margins. The stock offers an attractive risk/reward with a 3%+ dividend, modest leverage and ROE that can expand as margins and fees grow. We recommend a mid-term long with discipl…

Alphabet: Buy the AI-Scale Discount in a $4.2T Franchise

Alphabet: Buy the AI-Scale Discount in a $4.2T Franchise

Alphabet is trading like an ordinary tech name while running one of the most compelling AI franchises. At roughly $4.2 trillion market cap and a P/E near 17x, the poster child of AI infrastructure investment looks relatively cheap versus the optionality in Google Cloud, Gemini Enterprise adoption, and an expanding AI capex cycle. This trade outline…

Why Apple Looks Like a Steady Hold — Not a Home Run From Here

Why Apple Looks Like a Steady Hold — Not a Home Run From Here

Apple is a cash-generative giant with a $4.46 trillion market cap and healthy margins, but at roughly $305.69 today the stock already prices a lot of growth. Technicals show lagging momentum and valuation sits near historical premium levels. For traders, a conservative swing-long with a clear stop and limited upside target is a practical way to par…

Funding Growth From Production: Mako Mining's Expansion Trade Setup

Funding Growth From Production: Mako Mining's Expansion Trade Setup

Mako Mining ($MAKO) is trading just under $10 with a market cap near $863M. Technical momentum is constructive and the company’s San Albino focus positions it to convert operating cash flow into additional projects. This trade favors a directional long with defined entry, stop and target tied to operational and news catalysts over the next 180 trad…

FDA eGFR Readout Backs a Speculative Long on Vera Therapeutics

FDA eGFR Readout Backs a Speculative Long on Vera Therapeutics

Vera Therapeutics' recent regulatory win and underlying kidney function data create a buyable dip for traders willing to accept biotech execution and commercial risks. Market cap near $2.3B prices in success, but short interest, healthy liquidity and an improving technical setup make a defined-risk long trade attractive over a mid-term horizon.

Cisco After the Drop: Buy the AI-Driven Dip, Not the Fear

Cisco After the Drop: Buy the AI-Driven Dip, Not the Fear

Cisco's recent pullback looks like an overreaction. The company just raised its AI order target to $9 billion and still generates ~$11.8 billion of free cash flow annually while trading at a mid-30s P/E. This trade idea lays out an entry at $112.41 with tight risk control and a $125 target over a mid-term horizon.

Valneva After VALOR: Why the Lyme Royalty Shift Reprices the Stock

Valneva After VALOR: Why the Lyme Royalty Shift Reprices the Stock

Valneva's partnership with Pfizer and the messy VALOR readout shifted the firm's path from a potential commercial blockbuster to a royalty/milestone-oriented business. That change reduces binary clinical risk but also recasts valuation. With a market cap near $676M, recent product sales and a still-meaningful cash cushion, the shares offer an asymm…

WeRide: Tactical Long After a Convincing Q2 - Plan for a Mid-Term Bounce

WeRide: Tactical Long After a Convincing Q2 - Plan for a Mid-Term Bounce

WeRide's latest quarter surprised the market and reset expectations for commercialization pace. We like a tactical long here: the company is showing improving revenue and better-than-feared unit economics, while market sentiment remains fragile. The trade is sized for a mid-term rebound and uses tight risk controls to respect headline risk in auton…